1. Home
  2. UNB vs KRRO Comparison

UNB vs KRRO Comparison

Compare UNB & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Bankshares Inc.

UNB

Union Bankshares Inc.

HOLD

Current Price

$23.04

Market Cap

121.6M

Sector

Finance

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$11.98

Market Cap

139.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNB
KRRO
Founded
1891
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.6M
139.0M
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
UNB
KRRO
Price
$23.04
$11.98
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $20.20
AVG Volume (30 Days)
2.2K
★ 163.0K
Earning Date
10-21-2026
11-11-2026
Dividend Yield
★ 6.31%
N/A
EPS Growth
★ 25.52
N/A
EPS
★ 1.25
N/A
Revenue
N/A
★ $6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$56.67
P/E Ratio
$18.44
★ N/A
Revenue Growth
N/A
★ 181.46
52 Week Low
$20.65
$5.20
52 Week High
$26.41
$42.70

Technical Indicators

Market Signals
Indicator
UNB
KRRO
Relative Strength Index (RSI) 47.19 63.86
Support Level $22.89 $10.18
Resistance Level $24.16 $12.54
Average True Range (ATR) 0.36 1.00
MACD 0.03 0.38
Stochastic Oscillator 33.99 97.35

Price Performance

Historical Comparison
UNB
KRRO

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The Company has one definable business segment, Union Bank, which provides full retail, commercial, municipal banking, and wealth management and trust services throughout its 18 branch banking locations, three loan centers, and several ATMs covering northern Vermont and northern New Hampshire. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: